Form 4 for GNLX GENELUX Corp
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0001641172-25-026396 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-03 | 2025-09-01 | GNLX | Smalling Ralph | Head of Regulatory | A - Grant | $0.00 | +10.0K | 71.0K | +16% | $0 |
| D | 2025-09-03 | 2025-09-01 | GNLX | Smalling Ralph | Head of Regulatory | D - Sale to Iss | — | -8,333 | 0 | -100% | — |
| D | 2025-09-03 | 2025-09-01 | GNLX | Smalling Ralph | Head of Regulatory | A - Grant | — | +8,333 | 8,333 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-01 | A | A | 10,000 | $0.00 | 70,990 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-09-01 | D | D | 8,333 | — | 0 | D | $6.00 · — to 2030-09-23 | 8,333 Common stock | (F3) The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option. (F2) The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-09-01 | A | A | 8,333 | — | 8,333 | D | $3.33 · — to 2030-09-23 | 8,333 Common stock | (F3) The transactions reported herein reflect a one-time reduction of the exercise price of the stock option, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration date or the vesting schedule of the stock option. (F2) The shares subject to the option vest as follows: 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 36 equal monthly installments thereafter. |